Latest Breaking News On - Gx1321 - Page 1 : comparemela.com

Marios Giannakis, MD, PhD, discusses preliminary efficacy data from a phase 1 study of CGX1321 with or without pembrolizumab in advanced gastrointestinal tumors.

United statesMarios giannakisDana farber cancer instituteHarvard medical schoolGastrointestinal cancer centerOnclive tvGastrointestinal cancer